Plasmocytoid urothelial carcinoma - clinical, histological, immunohistochemical and molecular aspects
Abstract Plasmacytoid (PUC) variant is a rare and aggressive form of urothelial cancer representing 1 to 3% of the bladder cancer. The main differential diagnosis is the bladder involvement by lymphoma-plasmocytoma or metastasis from lobular breast cancer or diffuse gastric cancer. Immunexpression o...
Main Author: | Katia Ramos Moreira Leite |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-01-01
|
Series: | Surgical and Experimental Pathology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s42047-020-0056-5 |
Similar Items
-
Poor Outcome due to the Plasmacytoid Variant of Urothelial Carcinoma
by: Kyotaro Fukuta, et al.
Published: (2022-03-01) -
Nested variant of urothelial carcinoma of the urinary bladder
by: Tadashi Terada
Published: (2011-12-01) -
Expression of epithelial-Mesenchymal transition related markers in Plasmacytoid Urothelial carcinoma of the urinary bladder
by: Shunichiro Nomura, et al.
Published: (2020-06-01) -
Clinically undetected plasmacytoid urothelial carcinoma of the urinary bladder with non-mass-forming metastases in multiple organs: an autopsy case
by: Yuya Asano, et al.
Published: (2022-07-01) -
Immunohistochemical Expression of Estrogen Receptor Beta in Urothelial Carcinoma of the Urinary Bladder
by: Omnia M.M. Badawy *, et al.
Published: (2023-07-01)